Surrogate thrombopoietin

被引:4
作者
Abe, M
Yano, S
Sakaba, N
Kitamura, K
Urasaki, T
Nakada, S
Kawasaki, H
Morimoto, C
Masuho, Y
机构
[1] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 305, Japan
[2] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 108, Japan
关键词
thrombopoietin; c-Mpl; agonistic antibody; Fab;
D O I
10.1016/S0165-2478(97)00166-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The extracellular domain of human c-Mpl, the receptor for thrombopoietin (TPO), was expressed as a chimeric protein with the interleukin-2 receptor alpha chain on the surface of murine B cell-line B300-19. BALB/c mice were immunized with cells expressing the chimeric protein. The IgG purified from the resulting immune serum immunoprecipitated human c-Mpl. The immune IgG supported proliferation of both stable transfectant Ba/F3 cells expressing whole c-Mpl molecules (c-Mpl-Ba/F3 No. 9) and UT7/TPO cells bearing naturally occuring c-Mpl, whereas it did not support the growth of the untransfected parental Ba/F3 cells. Cell growth was induced using 3 to 100 mu g/ml of immune IgG in a dose-dependent manner, but this induction was decreased at doses higher than 100 mu g/ml. Non-immune IgG did not affect cell growth of c-Mpl-Ba/F3 No. 9 cells. Although the Fab fragment of immune IgG also immunoprecipitated c-Mpl, it did not support cell growth at concentrations as high as 180 mu g/ml, implying that the bivalent binding of receptors by antibodies is essential for cell proliferation. These results suggest that antibodies against human c-Mpl stimulate the proliferation and differentiation of megakaryocytes by their bivalent binding to receptors like TPO. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 19 条
[1]   Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl [J].
Alexander, WS ;
Roberts, AW ;
Nicola, NA ;
Li, RL ;
Metcalf, D .
BLOOD, 1996, 87 (06) :2162-2170
[2]   POINT MUTATIONS WITHIN A DIMER INTERFACE HOMOLOGY DOMAIN OF C-MPL INDUCE CONSTITUTIVE RECEPTOR ACTIVITY AND TUMORIGENICITY [J].
ALEXANDER, WS ;
METCALF, D ;
DUNN, AR .
EMBO JOURNAL, 1995, 14 (22) :5569-5578
[3]   REGULATION OF PLATELET ACTIVATION IN-VITRO BY THE C-MPL LIGAND, THROMBOPOIETIN [J].
CHEN, JC ;
HERCEGHARJACEK, L ;
GROOPMAN, JE ;
GRABAREK, J .
BLOOD, 1995, 86 (11) :4054-4062
[4]   THE HEMATOPOIETIN RECEPTOR SUPERFAMILY [J].
COSMAN, D .
CYTOKINE, 1993, 5 (02) :95-106
[5]   DIMERIZATION OF THE EXTRACELLULAR DOMAIN OF THE HUMAN GROWTH-HORMONE RECEPTOR BY A SINGLE HORMONE MOLECULE [J].
CUNNINGHAM, BC ;
ULTSCH, M ;
DEVOS, AM ;
MULKERRIN, MG ;
CLAUSER, KR ;
WELLS, JA .
SCIENCE, 1991, 254 (5033) :821-825
[6]   Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine [J].
Cwirla, SE ;
Balasubramanian, P ;
Duffin, DJ ;
Wagstrom, CR ;
Gates, CM ;
Singer, SC ;
Davis, AM ;
Tansik, RL ;
Mattheakis, LC ;
Boytos, CM ;
Schatz, PJ ;
Baccanari, DP ;
Wrighton, NC ;
Barrett, RW ;
Dower, WJ .
SCIENCE, 1997, 276 (5319) :1696-1699
[7]   Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies [J].
Elliott, S ;
Lorenzini, T ;
Yanagihara, D ;
Chang, D ;
Elliott, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24691-24697
[8]   THROMBOCYTOPENIA IN C-MPL-DEFICIENT MICE [J].
GURNEY, AL ;
CARVERMOORE, K ;
DESAUVAGE, FJ ;
MOORE, MW .
SCIENCE, 1994, 265 (5177) :1445-1447
[9]  
KAUSHANSKY K, 1995, INT J HEMATOL, V62, P7
[10]   A sequential dimerization mechanism for erythropoietin receptor activation [J].
Matthews, DJ ;
Topping, RS ;
Cass, RT ;
Giebel, LB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9471-9476